![]() |
Siga Technologies, Inc. (SIGA) DCF Valoración
US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
|

- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
SIGA Technologies, Inc. (SIGA) Bundle
¡Explore SIGA Technologies, Inc. (SIGA) Outlook financiero con nuestra calculadora DCF fácil de usar! Ingrese sus proyecciones para el crecimiento, los márgenes y los gastos para calcular el valor intrínseco de Siga e informar sus decisiones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 26.7 | 125.0 | 133.7 | 110.8 | 139.9 | 180.5 | 233.0 | 300.6 | 387.9 | 500.6 |
Revenue Growth, % | 0 | 367.28 | 6.97 | -17.13 | 26.31 | 29.04 | 29.04 | 29.04 | 29.04 | 29.04 |
EBITDA | 1.0 | 85.0 | 89.6 | 43.2 | 84.2 | 86.0 | 110.9 | 143.2 | 184.7 | 238.4 |
EBITDA, % | 3.84 | 68.05 | 67.04 | 39.01 | 60.15 | 47.62 | 47.62 | 47.62 | 47.62 | 47.62 |
Depreciation | .5 | .5 | .5 | .5 | .5 | 1.3 | 1.7 | 2.2 | 2.8 | 3.6 |
Depreciation, % | 1.97 | 0.42399 | 0.39079 | 0.46729 | 0.38472 | 0.72749 | 0.72749 | 0.72749 | 0.72749 | 0.72749 |
EBIT | .5 | 84.5 | 89.1 | 42.7 | 83.6 | 84.7 | 109.2 | 141.0 | 181.9 | 234.7 |
EBIT, % | 1.87 | 67.62 | 66.65 | 38.55 | 59.76 | 46.89 | 46.89 | 46.89 | 46.89 | 46.89 |
Total Cash | 65.2 | 117.9 | 103.1 | 98.8 | 150.1 | 166.3 | 214.7 | 277.0 | 357.4 | 461.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 4.2 | 3.3 | 83.7 | 45.4 | 21.1 | 49.4 | 63.8 | 82.3 | 106.2 | 137.1 |
Account Receivables, % | 15.59 | 2.67 | 62.58 | 40.99 | 15.1 | 27.39 | 27.39 | 27.39 | 27.39 | 27.39 |
Inventories | 9.7 | 20.3 | 19.5 | 39.3 | 64.2 | 53.5 | 69.1 | 89.1 | 115.0 | 148.4 |
Inventories, % | 36.1 | 16.22 | 14.6 | 35.45 | 45.9 | 29.65 | 29.65 | 29.65 | 29.65 | 29.65 |
Accounts Payable | 3.1 | 1.3 | 2.0 | 3.4 | 1.5 | 6.5 | 8.4 | 10.8 | 14.0 | 18.1 |
Accounts Payable, % | 11.42 | 1.02 | 1.52 | 3.03 | 1.04 | 3.61 | 3.61 | 3.61 | 3.61 | 3.61 |
Capital Expenditure | .0 | .0 | -.1 | .0 | .0 | -.1 | -.1 | -.1 | -.1 | -.2 |
Capital Expenditure, % | -0.10879 | -0.01240484 | -0.03786925 | 0 | -0.01549916 | -0.03491361 | -0.03491361 | -0.03491361 | -0.03491361 | -0.03491361 |
Tax Rate, % | 22.45 | 22.45 | 22.45 | 22.45 | 22.45 | 22.45 | 22.45 | 22.45 | 22.45 | 22.45 |
EBITAT | .4 | 64.8 | 69.3 | 32.8 | 64.8 | 64.3 | 83.0 | 107.1 | 138.2 | 178.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -9.9 | 53.7 | -9.1 | 53.1 | 62.8 | 53.0 | 56.6 | 73.0 | 94.3 | 121.6 |
WACC, % | 8.44 | 8.44 | 8.45 | 8.44 | 8.45 | 8.44 | 8.44 | 8.44 | 8.44 | 8.44 |
PV UFCF | ||||||||||
SUM PV UFCF | 303.5 | |||||||||
Long Term Growth Rate, % | 3.50 | |||||||||
Free cash flow (T + 1) | 126 | |||||||||
Terminal Value | 2,546 | |||||||||
Present Terminal Value | 1,697 | |||||||||
Enterprise Value | 2,001 | |||||||||
Net Debt | -150 | |||||||||
Equity Value | 2,150 | |||||||||
Diluted Shares Outstanding, MM | 72 | |||||||||
Equity Value Per Share | 30.00 |
What You Will Get
- Pre-Filled Financial Model: SIGA Technologies' actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers tailored for SIGA (SIGA).
- Instant Calculations: Automatic updates ensure you see results as you make changes to SIGA's financials.
- Investor-Ready Template: A refined Excel file designed for professional-grade valuation of SIGA (SIGA).
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts of SIGA (SIGA).
Key Features
- Comprehensive SIGA Data: Pre-loaded with SIGA Technologies’ historical performance metrics and future projections.
- Tailorable Inputs: Modify growth rates, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Model: Real-time updates to Net Present Value (NPV) and intrinsic valuation based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive Interface: Clean, organized, and crafted for both industry professionals and novices.
How It Works
- Step 1: Download the prebuilt Excel template featuring SIGA Technologies, Inc. (SIGA) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including SIGA's intrinsic value.
- Step 5: Utilize the outputs to make informed investment choices or create comprehensive reports.
Why Choose SIGA Technologies, Inc. (SIGA)?
- Innovative Solutions: Access cutting-edge technologies that address critical health challenges.
- Proven Track Record: Established history of delivering effective therapeutics for infectious diseases.
- Expert Team: Collaborate with industry leaders and scientists dedicated to advancing public health.
- Commitment to Quality: Rigorous standards ensure the highest level of product safety and efficacy.
- Investor Confidence: Backed by a solid financial foundation and a clear growth strategy.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment of SIGA Technologies, Inc. (SIGA).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations regarding SIGA.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in SIGA Technologies, Inc. (SIGA) investments.
- Students and Educators: Utilize real-world data to enhance financial modeling skills and education focused on SIGA.
- Biotech Enthusiasts: Gain insights into how biotech firms like SIGA Technologies, Inc. (SIGA) are valued in the marketplace.
What the Template Contains
- Preloaded SIGA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.